Patents by Inventor Jason Lamar VITTITOW

Jason Lamar VITTITOW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING COVID-19 WITH RIFAXIMIN
    Publication number: 20230116647
    Abstract: Provided herein are methods for treating COVID-19 or associated GI symptoms with rifaximin compositions.
    Type: Application
    Filed: March 24, 2021
    Publication date: April 13, 2023
    Inventors: Maxime Barakat, Howard Franklin, Zeev Heimanson, Thejasvi Ramakrishna, Jason Lamar Vittitow
  • SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY
    Publication number: 20230111568
    Abstract: Provided herein are solid dispersions comprising rifaximin and methods of using the same for the treatment of Overt Hepatic Encephalopathy and complications associated with cirrhosis.
    Type: Application
    Filed: March 24, 2021
    Publication date: April 13, 2023
    Inventors: Zeev Heimanson, Robert J. Israel, Thejasvi Ramakrishna, Jason Lamar Vittitow
  • Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
    Patent number: 11058691
    Abstract: This invention provides a method of lowering intraocular pressure in a patient having normal tension glaucoma, comprising contacting an eye of a subject having normal tension glaucoma with a pharmaceutical composition comprising an effective amount of Nitric Oxide releasing prostaglandin derivatives of formula (I).
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: July 13, 2021
    Assignees: Nicox S.A., Bausch & Lomb Incorporated
    Inventors: Jason Lamar Vittitow, Megan Elizabeth Cavet
  • NITRIC OXIDE RELEASING PROSTAGLANDIN DERIVATIVES FOR TREATING NORMAL TENSION GLAUCOMA
    Publication number: 20200179401
    Abstract: This invention provides a method of lowering intraocular pressure in a patient having normal tension glaucoma, comprising contacting an eye of a subject having normal tension glaucoma with a pharmaceutical composition comprising an effective amount of Nitric Oxide releasing prostaglandin derivatives of formula (I).
    Type: Application
    Filed: November 7, 2017
    Publication date: June 11, 2020
    Inventors: Jason Lamar VITTITOW, Megan Elizabeth CAVET